Lexapro and Biopsy bone marrow abnormal - a phase IV clinical study of FDA data

Summary:

Biopsy bone marrow abnormal is reported as a side effect among people who take Lexapro (escitalopram oxalate), especially for people who are female, 50-59 old, also take Vicodin, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Biopsy bone marrow abnormal when taking Lexapro. It is created by eHealthMe based on reports of 82,231 people who have side effects when taking Lexapro from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Biopsy bone marrow abnormal?

Biopsy bone marrow abnormal is found to be associated with 275 drugs and 271 conditions by eHealthMe. Check the latest studies of Biopsy bone marrow abnormal.

On Aug, 11, 2026

82,231 people reported to have side effects when taking Lexapro.
Among them, 24 people (0.03%) have Biopsy bone marrow abnormal.

Could Lexapro cause Biopsy bone marrow abnormal?

Among these 24 people:

What is the gender of people who have Biopsy bone marrow abnormal when taking Lexapro? *

female: 54.17 %
male: 45.83 %

What is the age of people who have Biopsy bone marrow abnormal when taking Lexapro? *

What are other drugs people take besides Lexapro? *

What are other side effects people have besides Biopsy bone marrow abnormal? *

Sinusitis (inflammation of sinus): 16 people, 66.67%
Malaise (a feeling of general discomfort or uneasiness): 13 people, 54.17%
Fatigue (feeling of tiredness): 11 people, 45.83%
Headache (pain in head): 11 people, 45.83%
Cataract (clouding of the lens inside the eye): 10 people, 41.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 10 people, 41.67%
Chest Pain: 10 people, 41.67%
Weight Decreased: 9 people, 37.50%
Fall: 9 people, 37.50%
Fever: 9 people, 37.50%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 9 people, 37.50%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 16.67%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 8.33%
Pain: 2 people, 8.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.33%
Seasonal Allergy (allergic condition due to certain season): 1 person, 4.17%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 4.17%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 4.17%
Birth Control: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and have Biopsy bone marrow abnormal?

- Check whether Biopsy bone marrow abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lexapro:

Lexapro (91,464 reports)

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Biopsy bone marrow abnormal:

Biopsy bone marrow abnormal (275 drugs)

Browse all the conditions that are associated with Biopsy bone marrow abnormal:

Biopsy bone marrow abnormal (271 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Lexapro) and Lexapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.